Chandler Regional and Mercy Gilbert Medical Centers, Dignity Health members, have announced their participation in two new research studies to advance knowledge and treatment of heart disease.

The Chemometric Observation of Lipid Core Containing Plaques of Interest in Native Coronary Artery (COLOR) Registry Study will be led by principal investigator Nabil Dib, M.D., M.Sc., F.A.C.C., director of Cardiovascular Research at Mercy Gilbert and Chandler Regional Medical Centers. Its purpose is to obtain more information about plaques and their role in management of coronary artery disease.

The Prospective, Open-Label Anti-Platelet Therapy Study will help to determine whether availability of platelet function testing results will change a doctor’s decision about which antiplatelet drug and dosage he or she prescribes to heart attack patients.

For more information, call (480) 728-9979. Visit online at ChandlerRegional.org/Research or MercyGilbert.org/Research.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.